Straightening out the wrinkles in technetium-99m-labeled bone scintigraphy tracer assessment of cardiac amyloidosis

Affiliations

¹ Department of Cardiac Imaging, University of Ottawa Heart Institute, Ottawa, ON, K1Y 4W7, Canada.
² Department of Cardiac Imaging, University of Ottawa Heart Institute, Ottawa, ON, K1Y 4W7, Canada. gsmall@ottawaheart.ca.

Editorial

Gary R Small et al. J Nucl Cardiol. 2021 Feb.

. 2021 Feb;28(1):100-103.

doi: 10.1007/s12350-019-01718-8. Epub 2019 Apr 11.

¹ Department of Cardiac Imaging, University of Ottawa Heart Institute, Ottawa, ON, K1Y 4W7, Canada.
² Department of Cardiac Imaging, University of Ottawa Heart Institute, Ottawa, ON, K1Y 4W7, Canada. gsmall@ottawaheart.ca.

No abstract available

Comment on

Semi-quantitative indices of cardiac uptake in patients with suspected cardiac amyloidosis undergoing 99mTc-HMDP scintigraphy.
Gallini C, Tutino F, Martone R, Ciaccio A, Costanzo EN, Taborchi G, Morini S, Bartolini S, Farsetti S, Di Mario C, Perfetto F, Cappelli F. Gallini C, et al. J Nucl Cardiol. 2021 Feb;28(1):90-99. doi: 10.1007/s12350-019-01643-w. Epub 2019 Feb 14. J Nucl Cardiol. 2021. PMID: 30767162

1. Falk RH. Diagnosis and management of the cardiac amyloidoses. Circulation 2005;112(13):2047-60. - DOI
1. Singh V, Falk R, Di Carli MF, Kijewski M, Rapezzi C, Dorbala S. State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis. J Nucl Cardiol 2019;26(1):158-73. - DOI
1. Dorbala S, Bokhari S, Miller E, Bullock-Palmer R, Soman P, Thompson R. 99m Technetium-pyrophosphate imaging for transthyretin cardiac amyloidosis. ASNC Practice Points 2016.
1. Perugini E, Guidalotti PL, Salvi F, Cooke RM, Pettinato C, Riva L, et al. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. J Am Coll Cardiol 2005;46(6):1076-84. - DOI
1. Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation 2016;133(24):2404-12. - DOI